Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockadeDavid Ciccone, Christine Loh, Neelu Kaila et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Knowledge andStructure-Based Drug Design of 15-PGDHInhibitorsLeela S. Dodda, Neelu Kaila, Sébastien Campos et al.|Journal of Medicinal Chemistry|2025Cited by 0